Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in IHE
17.1%
% of IHE's 36 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.0% | 21.8% | 16.0% |
|
JOHNSON & JOHNSON | 4.4% | 23.5% | 4.4% |
|
PFIZER INC | 4.3% | 4.8% | 4.3% |
|
MERCK & CO. INC. | 4.7% | 4.3% | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 4.4% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to IHE
|
ABBVIE INC | 7.4% |
|
AMGEN INC | 6.2% |
 |
NOVARTIS AG-ADR | 5.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% |
|
REGENERON PHARMACEUTICALS | 4.3% |
|
BIOGEN IDEC INC | 3.9% |
|
ALNYLAM PHARMACEUTICALS INC | 3.8% |
|
IONIS PHARMACEUTICALS, INC. | 3.3% |
|
CRISPR THERAPEUTICS AG | 3.2% |
 |
ALKERMES PLC | 3.2% |
MEDX Underweight Relative to IHE
|
JOHNSON & JOHNSON | -19.1% |
|
ELI LILLY & CO | -5.8% |
|
VIATRIS, INC. | -4.7% |
|
ZOETIS INC | -4.5% |
|
ROYALTY PHARMA PLC CLASS A | -4.4% |
|
CATALENT INC | -4.2% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
JAZZ PHARMACEUTICALS PLC | -2.8% |
|
ELANCO ANIMAL HEALTH, INC. | -2.5% |
|
ORGANON & CO. | -2.2% |